Notícias

OpenAI doesn't look likely to launch an IPO this year but investors could get a proxy for the ChatGPT developer in the form of SB Energy.

NVIDIA Corp CEO Jensen Huang may not check the price of the stock for the company he runs and co-founded, but millions of other investors do daily. With shares soaring after second-quarter financial results, Nvidia stock is nearing an all-time...

AI could accelerate X-Energy's path toward commercial nuclear power.

A slowdown in AI model development won't fix OpenAI's financial woes.

Next-generation nuclear reactors need fuel, and Standard Nuclear is one of the companies that provides it.

The long-running dispute between OpenAI CEO Sam Altman and Elon Musk has simmered for years, rooted in Musk’s exit from the AI lab he co-founded and his subsequent legal and public challenges over its direction. That rivalry just moved from boardroom barbs to operational consequences. On Friday, OpenAI cut off model access for Cursor after […]

History says SpaceX shareholders will lose money in the coming months.

Nvidia is writing a check to fund a company that turns around and buys Nvidia chips, and Jensen Huang sees nothing circular about that arrangement. Whether Perplexity's explosive revenue growth justifies a $30 billion valuation depends on math that neither party fully controls.

Artificial intelligence developer Anthropic PBC has committed $45 billion to lease AI cloud computing infrastructure from London-based Nscale.

Critical Metals is surging nearly 20% while its rare earth peers sit flat or slide lower, and no company announcement explains the gap. One unverified catalyst keeps surfacing in trader circles, and it has nothing to do with the ground under Greenland.

Lambda, an AI cloud-computing provider backed by Nvidia (NVDA), is in talks to raise as much as $3 b

Two companies –- OpenAI and Anthropic –- are driving the AI industry forward as everything from hyperscalers to neoclouds to memory stocks hangs on the demand for tokens.

Nvidia is effectively centralizing the artificial intelligence supply chain by bypassing traditional mergers and acquisitions in favor of a repeatable, non-traditional financial mechanism. By deploying a licensing-plus-hire strategy, the company absorbs the operational capacity of critical AI startups while avoiding the regulatory scrutiny that typically accompanies full-scale corporate integration. This approach, most recently evidenced by […]

One restaurant chain is trading at a sky-high valuation while another has shed double digits this year, and the market's verdict defies everything a shaky consumer economy would predict about which business wins.

Seaport Therapeutics just went public with a prodrug platform that has attracted board members from two of the biggest neuroscience acquisitions in recent history. The question is whether the same giants who funded those deals are already circling for a third.

Moderna's stock just surged in a way that transforms the company from a cash-burning vaccine maker into a serious acquirer, and four biotech targets already sit within striking range of its newly loaded war chest.

Amazon invested just $13 billion in Anthropic.

Anthropic just posted numbers that made OpenAI's growth look slow, and now it wants a $2 trillion valuation at IPO. Whether that price tag reflects a genuine breakthrough or a dangerous case of AI fever is the question every investor needs to answer before the market opens.

Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.

The company's struggling shares are launching back into orbit.

Crusoe IPO looms after last funding round valued the AI data center developer at $10 billion. Reports suggest firm's valuation may triple.

A Plexo Capital partner who owns Anthropic shares went on CNBC to defend a valuation that dwarfs every profitable public AI company, and the caveat he buried in his own argument may be the most important thing he said.

Kailera Therapeutics raised one of the biggest obesity biotech IPOs in recent memory, then watched its stock drop nearly 30%. Now several of the world's largest drugmakers have a compelling reason to make a move before pivotal trial data arrives.

Ackman put new capital to work in the second quarter of the year.

FORT Robotics plans to go public through a business combination with Newbury Street II Acquisition (

A top market strategist just called out the biggest risk hiding inside Anthropic's upcoming IPO, and it has nothing to do with the quality of the company or its technology.

This company's human-powered platform bucks the artificial intelligence (AI) trend.

Nvidia stock touched $227 a share Monday on news it's pouring $1.5 billion into this AI data center and energy player.

Companies try to get deals done while regulators allow them. But are buyouts always a good idea?

For investors who want to bet on a future rebound in the U.S. housing market, this homebuilder ETF could be a good buy today.